Severe Paroxysmal supraventricular tachycardia

Drug	Drug Name	Drug Description
DB01195	Flecainide	A class Ic antiarrhythmic agent used to manage atrial fibrillation and paroxysmal supraventricular tachycardias (PSVT).

Drug	Drug Name	Target	Type
DB01195	Flecainide	Sodium channel protein type 5 subunit alpha	target
DB01195	Flecainide	Cytochrome P450 2D6	enzyme
DB01195	Flecainide	Sodium channel protein type 4 subunit alpha	target
DB01195	Flecainide	Cytochrome P450 2C9	enzyme
DB01195	Flecainide	Potassium voltage-gated channel subfamily H member 2	target
DB01195	Flecainide	alpha1-acid glycoprotein	carrier
DB01195	Flecainide	Serum albumin	carrier
DB01195	Flecainide	Cytochrome P450 1A2	enzyme
DB01195	Flecainide	P-glycoprotein 1	transporter
DB01195	Flecainide	Multidrug and toxin extrusion protein 1	transporter
DB01195	Flecainide	Ryanodine receptor 2	target

Drug	Drug Name	Phase	Status	Count